162 related articles for article (PubMed ID: 1967552)
1. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
Natali P; Nicotra MR; Cavaliere R; Bigotti A; Romano G; Temponi M; Ferrone S
Cancer Res; 1990 Feb; 50(4):1271-8. PubMed ID: 1967552
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
Kageshita T; Yoshii A; Kimura T; Kuriya N; Ono T; Tsujisaki M; Imai K; Ferrone S
Cancer Res; 1993 Oct; 53(20):4927-32. PubMed ID: 8104688
[TBL] [Abstract][Full Text] [Related]
5. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
6. Differential role of distinct determinants of intercellular adhesion molecule-1 in immunologic phenomena.
Maio M; Tessitori G; Pinto A; Temponi M; Colombatti A; Ferrone S
J Immunol; 1989 Jul; 143(1):181-8. PubMed ID: 2471735
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
8. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
[TBL] [Abstract][Full Text] [Related]
9. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
10. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
12. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
15. Expression of intercellular adhesion molecule-1 (ICAM-1) in benign naevi and malignant melanomas.
Hansen NL; Ralfkiaer E; Hou-Jensen K; Thomsen K; Drzewiecki KT; Rothlein R; Vejlsgaard GL
Acta Derm Venereol; 1991; 71(1):48-51. PubMed ID: 1676215
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
17. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
18. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
Miele ME; Bennett CF; Miller BE; Welch DR
Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
[TBL] [Abstract][Full Text] [Related]
19. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.
van Duinen SG; Ruiter DJ; Broecker EB; van der Velde EA; Sorg C; Welvaart K; Ferrone S
Cancer Res; 1988 Feb; 48(4):1019-25. PubMed ID: 3338074
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen.
Kraus A; Masat L; Johnson JP
Melanoma Res; 1997 Aug; 7 Suppl 2():S75-81. PubMed ID: 9578420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
